JoVE Logo

로그인

4.14 : Combined Effects of Drugs: Antagonism

The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.

The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by binding to the same receptor. This prevents the agonist drug from activating the receptor and producing its intended effect. For example, naloxone, a competitive antagonist, can block the effects of opioid drugs by binding to opioid receptors and reversing their activation.

In addition, functional or physiological antagonism occurs when a drug binds to a different receptor and produces a physiological response that opposes the effect of the agonist-bound receptor. For example, histamine stimulates acid secretion, while omeprazole prevents acid secretion by inhibiting the proton pump. These drugs can be considered functional antagonists.

Some drugs follow chemical antagonism, which involves the combination of two drugs to form an inactive product. Examples include chelating agents like dimercaprol, which bind to heavy metals and reduce their toxicity. The neutralizing antibody infliximab, which sequesters the inflammatory cytokine tumor necrosis factor (TNF), has an anti-inflammatory effect.

Antagonism can also occur through pharmacokinetic interactions, where one drug affects another drug's absorption, distribution, metabolism, or elimination. For instance, if a drug increases the metabolism or elimination of another drug, it can decrease the concentration and effectiveness of the second drug, leading to antagonistic effects.

Tags

AntagonismDrug InteractionReceptor BindingAllosteric ModulationFunctional InteractionChemical ReactionsPharmacokinetic ProcessesReceptor AntagonismCompetitive AntagonistOpioid ReceptorsPhysiological AntagonismChelating AgentsInfliximabTumor Necrosis Factor TNFDrug Metabolism

장에서 4:

article

Now Playing

4.14 : Combined Effects of Drugs: Antagonism

Pharmacodynamics

8.2K Views

article

4.1 : 약물 작용의 원칙

Pharmacodynamics

5.7K Views

article

4.2 : 약물 작용의 목표: 개요

Pharmacodynamics

6.0K Views

article

4.3 : 신호 전달: 개요

Pharmacodynamics

8.1K Views

article

4.4 : 변환기 메커니즘: G 단백질 결합 수용체

Pharmacodynamics

1.8K Views

article

4.5 : 리간드 게이트 이온 채널 수용체: 게이팅 메커니즘

Pharmacodynamics

2.1K Views

article

4.6 : 변환기 메커니즘: 효소 결합 수용체

Pharmacodynamics

2.3K Views

article

4.7 : 트랜스듀서 메커니즘: 핵 수용체

Pharmacodynamics

1.3K Views

article

4.8 : 용량-반응 관계: 개요

Pharmacodynamics

2.9K Views

article

4.9 : 용량-반응 관계: 효능 및 효능

Pharmacodynamics

4.2K Views

article

4.10 : 용량-반응 관계: 선택성 및 특이성

Pharmacodynamics

6.4K Views

article

4.11 : 치료 지수

Pharmacodynamics

4.0K Views

article

4.12 : 약물-수용체 상호작용: 작용제

Pharmacodynamics

2.3K Views

article

4.13 : 약물-수용체 상호 작용: 길항제

Pharmacodynamics

2.7K Views

article

4.15 : 약물의 복합 효과: 시너지 효과

Pharmacodynamics

3.7K Views

See More

JoVE Logo

개인 정보 보호

이용 약관

정책

연구

교육

JoVE 소개

Copyright © 2025 MyJoVE Corporation. 판권 소유